If you’ve ever been to an AA or NA meeting, you know the ritual: The group breaks and half the room heads outside to smoke. It’s one of the most recognized features of the recovery community — so common it’s become a cultural shorthand, a cliché, a joke. But it reflects something real about addiction neuroscience, the lived experience of early recovery and the complicated relationship between harm reduction and long-term health. Understanding why nicotine is so prevalent in recovery — and what, if anything, to do about it — is worth taking seriously.
How Common Is Smoking in Recovery?
The general population smoking rate in the United States sits around 11% to 12%. Among people in active addiction treatment, rates are dramatically higher. Studies of people admitted to substance use treatment programs have found nicotine dependence in roughly 80% to 92% of patients. Research conducted at open AA meetings found about 57% of members reported being current smokers — a rate substantially lower than the 80% to 95% historically reported among people in active alcohol use disorder, which itself suggests that some people do quit smoking over the course of sustained sobriety. Still, the rate among AA members is roughly four to five times the national average.
Smoking and alcohol use have a well-documented bidirectional relationship. Alcohol increases cravings to smoke and raises smoking frequency. Nicotine, in turn, appears to reduce the subjective perception of intoxication, which can drive heavier drinking. People who drink heavily are significantly more likely to smoke than people who don’t, and smokers are two to three times more likely to engage in heavy drinking episodes. The overlap isn’t coincidental; it reflects shared neurochemistry.
The long-term health consequences of this pattern are severe. People who leave treatment having addressed their alcohol or drug use — but not their nicotine dependency — face significantly elevated mortality risk from smoking-related illness. Research from the Mayo Clinic found that people discharged following inpatient addiction treatment were more likely to die from smoking-related causes than from any other cause, including relapse to their primary substance.
Why Nicotine and Other Substances Share the Same Brain Circuitry
To understand why nicotine is so prevalent in people with substance use disorder — and why quitting smoking during early recovery feels particularly difficult — it helps to understand what all addictive substances have in common at the neurological level.
Every major drug of abuse, including alcohol, opioids, cocaine, methamphetamine and nicotine, activates the brain’s mesolimbic dopamine system. This is the circuit that registers reward, reinforces behavior and encodes the learning that shapes future choices. At its center is a pathway running from the ventral tegmental area in the midbrain to the nucleus accumbens, a region sometimes called the brain’s reward hub. When something activates this pathway — food, sex, social connection or a drug — dopamine floods the nucleus accumbens and the brain registers: Do that again.
Nicotine hijacks this system by binding to nicotinic acetylcholine receptors, triggering dopamine release within seconds of inhalation. The effect is fast, reliable and repeatable dozens of times per day with each cigarette. Over time, the brain adapts: Receptor populations change, baseline dopamine tone shifts and the system comes to require nicotine to function at what now feels like normal. Withdrawal produces not just physical discomfort but a genuine neurochemical deficit — reduced dopamine activity, elevated anxiety, difficulty concentrating — that resolves when nicotine is reintroduced.
What makes this particularly relevant for people in recovery from other substances is that the same dopamine system is already dysregulated from their primary addiction. Chronic alcohol or drug use produces lasting decreases in dopamine receptor density and dopamine activity during periods of abstinence. The brain, already running on a depleted dopamine system, is even more sensitive to the relief nicotine provides. This is the neurochemical foundation of what people in recovery often describe experientially: Cigarettes help them feel less raw, less irritable and more able to manage the stress of early sobriety. That’s not a rationalization. It’s an accurate description of what’s happening biochemically.
Nicotine as a Step Down: The Harm Reduction Perspective
Recovery rarely happens in a single vertical move from active addiction to full abstinence from all substances simultaneously. For many people, it happens in stages, along a continuum from more harmful to less harmful — and nicotine occupies a specific and somewhat paradoxical position on that continuum.
Tobacco smoking is itself deeply harmful: It remains the leading preventable cause of death in the United States, responsible for more than 480,000 deaths per year. There’s no harm-free form of nicotine use. But from a relative harm perspective, a person who’s replaced a fentanyl dependency, alcohol dependency or crack cocaine dependency with cigarettes and coffee has made a transition to substances that are far less acutely dangerous, less likely to produce impaired judgment leading to accidents or violence and far less likely to produce an overdose death. The AA and NA communities have implicitly recognized this for decades — not by endorsing tobacco, but by not making nicotine a focus of the recovery work, on the grounds that asking someone to simultaneously quit their primary substance and tobacco is a barrier that may undermine both efforts.
Research supports sequencing rather than simultaneous cessation. Some studies have found that attempting to quit smoking at the same time as addressing alcohol or drug use can increase stress and reduce the chances of success on both fronts, particularly in the earliest phases of recovery. The practical guidance that’s emerged from addiction medicine tends to support prioritizing the primary substance first, allowing the person to stabilize and then addressing tobacco when they’re in a stronger position to do so.
That said, the evidence isn’t uniform, and some research suggests smoking cessation doesn’t undermine sobriety — and may even support it. People who successfully quit smoking during or after treatment for alcohol or drug use disorder have been found to have better long-term sobriety outcomes than those who continue smoking. The relationship is complex, and the right timing is individual.
How Addiction Treatment Programs Approach Smoking Cessation
Historically, smoking was widely tolerated inside addiction treatment programs — as recently as a few decades ago, cigarettes were sometimes offered as a comfort measure during detox. Indoor smoking bans and a growing clinical awareness of tobacco’s long-term lethality have shifted this, but practices vary enormously across programs.
Many residential and outpatient treatment programs now integrate tobacco cessation into their programming, at least at the level of screening, brief intervention and referral. The most evidence-based pharmacological options for smoking cessation — nicotine replacement therapy (NRT) in its various forms, varenicline (Chantix), and bupropion — are increasingly available within treatment settings. Varenicline and bupropion both act on the dopamine system in ways that reduce nicotine craving and withdrawal, and bupropion is also an antidepressant, which makes it useful in people whose recovery is complicated by depression.
Nicotine replacement therapy — patches, gum, lozenges, inhalers, nasal spray — follows the harm reduction model explicitly. It delivers nicotine without the carcinogens and carbon monoxide produced by combustion, allowing the person to manage withdrawal and craving while reducing the acute harm of smoking. From there, the dose can be stepped down over time. Many people in recovery use NRT as a bridge, moving from cigarettes to a patch, then to lower-dose patches, then to intermittent products like gum or lozenges and eventually off nicotine entirely. Others stabilize on lower-harm nicotine delivery and stay there for years, which — while not ideal from a purely cessation-focused standpoint — represents real harm reduction relative to pack-a-day cigarette smoking.
Behavioral supports matter as well. The same cognitive behavioral and motivational tools that are used in addiction treatment generally — identifying triggers, developing coping strategies, building motivation to change — apply directly to nicotine. For people already engaged in recovery work, these aren’t unfamiliar skills. The challenge is often one of readiness and priority rather than capability.
What This Means If You Are in Recovery or Considering It
If you smoke and you’re working on recovery from alcohol or another substance, you’re not alone, and you’re not doing recovery wrong. The overlap between nicotine dependence and other substance use disorders is a feature of shared neurobiology, not a character flaw or a failure of commitment. Most addiction medicine clinicians don’t expect or require simultaneous tobacco cessation as a condition of treatment.
What’s worth knowing is that the same tools that support recovery from other substances are available for nicotine when you’re ready. Effective medications exist. Behavioral support helps. The step-down model — from cigarettes to less harmful nicotine delivery and potentially from there to cessation — is a legitimate and clinically supported path. And the evidence suggests that people who do eventually address their nicotine use tend to have stronger long-term recovery outcomes overall, not weaker ones.
If you’re looking for support for addiction of any kind, the National Rehab Hotline is available 24 hours a day. We can help connect you with treatment programs that address the full picture of your substance use — including, if relevant, tobacco — and offer evidence-based care at the appropriate level of intensity.
